CARDINAL HEALTH INC (CAH) Stock Analyst Earnings Estimates
NYSE:CAH - New York Stock Exchange, Inc. - US14149Y1082 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 181.364B 11.63% | 205.012B 13.04% | 226.827B 10.64% | 225.255B -0.69% | 244.686B 8.63% | 262.549B 7.30% | 274.968B 4.73% | 302.261B 9.93% | |
| EBITDA YoY % growth | 2.369B -8.88% | 2.466B 4.09% | 2.86B 15.98% | 3.257B 13.88% | 3.595B 10.38% | 3.861B 7.40% | N/A | N/A | |
| EBIT YoY % growth | 1.677B -7.71% | 1.774B 5.78% | 2.15B 21.20% | 2.702B 25.67% | 3.038B 12.44% | 3.273B 7.74% | 3.302B 0.89% | 3.504B 6.12% | |
| Operating Margin | 0.92% | 0.87% | 0.95% | 1.20% | 1.24% | 1.25% | 1.20% | 1.16% | |
| EPS YoY % growth | 5.06 -16.78% | 5.81 14.82% | 7.47 28.57% | 8.03 7.54% | 9.06 12.73% | 10.00 10.45% | 10.70 6.98% | 11.97 11.85% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.18 5.03% | 2.01 9.22% | 2.14 13.82% | 2.16 12.06% | 2.42 10.63% | 2.25 11.91% | 2.39 11.87% | 2.31 6.70% | 2.79 15.55% | 2.51 11.83% |
| Revenue Q2Q % growth | 55.877B 1.76% | 60.645B 1.30% | 58.716B 12.32% | 61.339B 10.99% | 58.739B 5.12% | 63.817B 5.23% | 66.057B 12.50% | 66.708B 8.75% | 64.694B 10.14% | 71.032B 11.31% |
| EBITDA Q2Q % growth | 877.04M -22.04% | 827.56M -33.90% | 849.04M 14.89% | 867.37M -7.73% | 932.84M 6.36% | 883.53M 6.76% | 893.28M 5.21% | 860.79M -0.76% | 986.07M 5.71% | 962.29M 8.91% |
| EBIT Q2Q % growth | 738.69M 22.91% | 682.99M 26.01% | 720.61M 29.37% | 736.92M 30.20% | 768.11M 3.98% | 700.83M 2.61% | 791.22M 9.80% | 760.1M 3.15% | 902.67M 17.52% | 806.71M 15.11% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.93 6.04% | 1.78 | 0.15 | 8.65% |
| Q1 2025 Q2Q % growth | 1.88 8.67% | 1.63 | 0.25 | 15.13% |
| Q4 2024 Q2Q % growth | 1.84 18.71% | 1.76 | 0.08 | 4.62% |
| Q3 2024 Q2Q % growth | 2.08 19.54% | 1.97 | 0.11 | 5.55% |
| Q2 2024 Q2Q % growth | 1.82 37.88% | 1.62 | 0.20 | 12.64% |
| Q1 2024 Q2Q % growth | 1.73 44.17% | 1.42 | 0.31 | 21.95% |
| Q4 2023 Q2Q % growth | 1.55 47.62% | 1.51 | 0.04 | 2.66% |
| Q3 2023 Q2Q % growth | 1.74 20.00% | 1.50 | 0.24 | 15.83% |
| Q2 2023 Q2Q % growth | 1.32 3.94% | 1.15 | 0.17 | 14.85% |
| Q1 2023 Q2Q % growth | 1.20 -6.98% | 0.95 | 0.25 | 26.10% |
| Q4 2022 Q2Q % growth | 1.05 -19.23% | 1.19 | -0.14 | -11.53% |
| Q3 2022 Q2Q % growth | 1.45 -5.23% | 1.54 | -0.09 | -5.87% |
| Q2 2022 Q2Q % growth | 1.27 -27.01% | 1.24 | 0.03 | 2.45% |
| Q1 2022 Q2Q % growth | 1.29 -14.57% | 1.34 | -0.05 | -3.68% |
| Q4 2021 Q2Q % growth | 1.30 25.00% | 1.21 | 0.09 | 7.29% |
| Q3 2021 Q2Q % growth | 1.53 -5.56% | 1.57 | -0.04 | -2.38% |
| Q2 2021 Q2Q % growth | 1.74 14.47% | 1.46 | 0.28 | 19.40% |
| Q1 2021 Q2Q % growth | 1.51 18.90% | 1.14 | 0.37 | 31.93% |
| Q4 2020 Q2Q % growth | 1.04 -6.31% | 0.93 | 0.11 | 12.43% |
| Q3 2020 Q2Q % growth | 1.62 1.89% | 1.45 | 0.17 | 11.94% |
| Q2 2020 Q2Q % growth | 1.52 17.83% | 1.23 | 0.29 | 23.28% |
| Q1 2020 Q2Q % growth | 1.27 -1.55% | 1.11 | 0.16 | 14.87% |
| Q4 2019 Q2Q % growth | 1.11 | 0.94 | 0.17 | 18.32% |
| Q3 2019 Q2Q % growth | 1.59 | 1.44 | 0.15 | 10.33% |
| Q2 2019 Q2Q % growth | 1.29 | 1.10 | 0.19 | 17.41% |
| Q1 2019 Q2Q % growth | 1.29 | 1.09 | 0.20 | 18.69% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 55.264B -3.80% | 55.567B | -303M | -0.55% |
| Q1 2025 Q2Q % growth | 52.277B -4.54% | 51.404B | 873M | 1.70% |
| Q4 2024 Q2Q % growth | 59.867B 12.00% | 59.285B | 582M | 0.98% |
| Q3 2024 Q2Q % growth | 54.911B 8.76% | 56.615B | -1.704B | -3.01% |
| Q2 2024 Q2Q % growth | 57.445B 11.61% | 57.583B | -138M | -0.24% |
| Q1 2024 Q2Q % growth | 54.763B 10.40% | 55.306B | -543M | -0.98% |
| Q4 2023 Q2Q % growth | 53.453B 13.57% | 53.246B | 207M | 0.39% |
| Q3 2023 Q2Q % growth | 50.487B 12.60% | 50.206B | 281M | 0.56% |
| Q2 2023 Q2Q % growth | 51.469B 13.23% | 51.251B | 218M | 0.43% |
| Q1 2023 Q2Q % growth | 49.603B 12.82% | 48.668B | 935M | 1.92% |
| Q4 2022 Q2Q % growth | 47.065B 10.52% | 45.161B | 1.904B | 4.22% |
| Q3 2022 Q2Q % growth | 44.836B 14.16% | 43.591B | 1.245B | 2.86% |
| Q2 2022 Q2Q % growth | 45.457B 9.43% | 46.028B | -571M | -1.24% |
| Q1 2022 Q2Q % growth | 43.968B 12.55% | 42.352B | 1.616B | 3.82% |
| Q4 2021 Q2Q % growth | 42.586B 16.07% | 40.828B | 1.758B | 4.31% |
| Q3 2021 Q2Q % growth | 39.275B 0.30% | 40.494B | -1.219B | -3.01% |
| Q2 2021 Q2Q % growth | 41.541B 4.55% | 41.852B | -311M | -0.74% |
| Q1 2021 Q2Q % growth | 39.065B 4.62% | 38.559B | 506M | 1.31% |
| Q4 2020 Q2Q % growth | 36.689B -1.78% | 37.04B | -351M | -0.95% |
| Q3 2020 Q2Q % growth | 39.157B 11.15% | 37.316B | 1.841B | 4.93% |
| Q2 2020 Q2Q % growth | 39.735B 5.29% | 39.826B | -91M | -0.23% |
| Q1 2020 Q2Q % growth | 37.341B 6.04% | 37.115B | 226M | 0.61% |
| Q4 2019 Q2Q % growth | 37.353B | 37.183B | 170M | 0.46% |
| Q3 2019 Q2Q % growth | 35.228B | 35.547B | -319M | -0.90% |
| Q2 2019 Q2Q % growth | 37.74B | 36.46B | 1.28B | 3.51% |
| Q1 2019 Q2Q % growth | 35.213B | 33.991B | 1.222B | 3.60% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.79% | 3.84% | 1.49% | 2.23% |
| Revenue | 3.15% | 7.35% | 1.08% | 1.76% |